BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Onchocerciasis

Below is an extended Onchocerciasis research listing. Click here to return to the Onchocerciasis main in depth entry.

Recent Publications on Onchocerciasis:

The global programme to eliminate lymphatic filariasis: health impact after 8 years.
BACKGROUND: In its first 8 years, the Global Programme to Eliminate...
Direct Link
9th October, 2008
Lymphatic Filariasis Support Center, Task Force for Child Survival and
Transmission dynamics of Simulium damnosum in rural communities of Akwa Ibom State, Nigeria. 9th October, 2008
Department of Zoology,
Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments.
SUMMARYRegular distribution of ivermectin reduces onchocerciasis...
Direct Link
4th October, 2008
Department of Primary Care & Population Sciences, Royal Free Hospital,
The neglected tropical diseases of latin america and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination.
The neglected tropical diseases (NTDs) represent some of the most common...
Direct Link
30th September, 2008
Department of Microbiology, Immunology, and Tropical Medicine, The George
Impact of long-term treatment with ivermectin on the prevalence and intensity of soil-transmitted helminth infections.
BACKGROUND: Control of soil-transmitted helminth (STH) infections relies...
Direct Link
30th September, 2008
Instituto de Microbiologia, Universidad San Francisco de Quito, Diego
Onchocerciasis control: biological research is still needed. 26th September, 2008
Institut de Recherche pour le Developpement, UR-024, 911, avenue
The Mectizan Donation Program (MDP).
The launch of the Mectizan Donation Program (MDP) in 1987, by Merck & Co.,...
Direct Link
26th September, 2008
Mectizan Donation Program, 325 Swanton Way, Decatur, GA 30030, USA.
The NGDO Co-ordination Group for Onchocerciasis Control.
Since the beginning of the donation of Mectizan by Merck & Co., Inc.,...
Direct Link
26th September, 2008
Helen Keller International, Regional Office for Africa, P.O. Box 29.898,
The World Bank.
The control of human onchocerciasis (river blindness) is one of the most...
Direct Link
26th September, 2008
Onchocerciasis Coordination Unit, World Bank Africa Region, Room J9-093,
The Onchocerciasis Elimination Program for the Americas (OEPA).
Human onchocerciasis (river blindness) occurs in 13 foci distributed among...
Direct Link
26th September, 2008
Onchocerciasis Elimination Program for the Americas (OEPA), 14 Calle 3-51
Special intervention zones.
The Special Intervention Zones (SIZ) of the former Onchocerciasis Control...
Direct Link
26th September, 2008
African Programme for Onchocerciasis Control, B. P. 549, Ouagadougou 01,
The African Programme for Onchocerciasis Control (APOC).
The African Programme for Onchocerciasis Control (APOC) was launched in...
Direct Link
26th September, 2008
African Programme for Onchocerciasis Control, B. P. 549, Ouagadougou 01,
The Onchocerciasis Control Programme in West Africa (OCP).
The Onchocerciasis Control Programme in West Africa (OCP) started...
Direct Link
26th September, 2008
UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in
The Mectizan Donation Program: 20 years of successful collaboration - a retrospective.
Merck is a global research-driven pharmaceutical company that, throughout...
Direct Link
26th September, 2008
Global Health Partnerships, Merck & Co., Inc., 1 Merck Drive, P. O. Box
Vision 2020 - the right to sight.
The unprecedented partnership for onchocerciasis control that followed...
Direct Link
26th September, 2008
Prevention of Blindness and Deafness, Chronic Diseases Prevention and
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional